col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Cell Host & Microbe
  original article Date Title Authors   All Authors
1 [GO] 2021―Aug―07 An AAV-based, room-temperature stable, single dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates Nerea Zabaleta, Wenlong Dai, Urja Bhatt, Cécile Hérate, Pauline Maisonnasse, Jessica A. Chichester, et al. (+48)
2 [GO] 2021―Jul―14 An aberrant inflammatory response in severe COVID-19 Miriam Merad, Aruna Subramanian, Taia T. Wang
3 [GO] 2021―Jul―14 Global COVID-19 vaccine inequity: The scope, the impact, and the challenges Archana Asundi, Colin O’Leary, Nahid Bhadelia
4 [GO] 2021―Jul―14 Children and SARS-CoV-2 Dusan Bogunovic, Miriam Merad
5 [GO] 2021―Jul―14 Virus hunters: Discovering the evolutionary origins of SARS-CoV-2 Arinjay Banerjee
6 [GO] 2021―Jul―14 SnapShot: SARS-CoV-2 antibodies David C. Montefiori, Priyamvada Acharya
7 [GO] 2021―Jul―14 The success of SARS-CoV-2 vaccines and challenges ahead Kanta Subbarao
8 [GO] 2021―Jul―14 The devil in the details: Herd immunity and pandemic response Beau Schaeffer, Bradford Taylor, Mary Bushman, William P. Hanage
9 [GO] 2021―Jun―24 Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease James Brett Case, Rita E. Chen, Longxing Cao, Baoling Ying, Emma S. Winkler, Max Johnson, et al. (+12)
10 [GO] 2021―Jun―17 Antibody and B cell responses to SARS-CoV-2 infection and vaccination Katharina Röltgen, Scott D. Boyd
11 [GO] 2021―Jun―15 SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity Chihiro Motozono, Mako Toyoda, Jiri Zahradnik, Akatsuki Saito, Hesham Nasser, Toong Seng Tan, et al. (+21)
12 [GO] 2021―Jun―04 A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T-cell responses Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, Shang Yu Gong, Romain Gasser, Guillaume Beaudoin-Bussières, et al. (+29)
13 [GO] 2021―Jun―03 HIV-1 and SARS-CoV-2: Patterns in the Evolution of Two Pandemic Pathogens Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, Kien Nguyen, Tanmoy Bhattarcharya, James Theiler, et al. (+9)
14 [GO] 2021―May―21 SARS-CoV-2 Human T cell Epitopes: adaptive immune response against COVID-19. Alba Grifoni, John Sidney, Randi Vita, Bjoern Peters, Shane Crotty, Daniela Weiskopf, Alessandro Sette
15 [GO] 2021―May―17 Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19 Shea A. Lowery, Alan Sariol, Stanley Perlman
16 [GO] 2021―May―03 Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans Kanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, Felix Dewald, Philipp Schommers, Lutz Gieselmann, et al. (+20)
17 [GO] 2021―Apr―19 Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Maple Wang, Jian Yu, Gabriele Cerutti, et al. (+5)
18 [GO] 2021―Apr―16 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection Hejun Liu, Meng Yuan, Deli Huang, Sandhya Bangaru, Fangzhu Zhao, Chang-Chun D. Lee, et al. (+14)
19 [GO] 2021―Mar―21 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, Lilin Lai, Meredith E. Davis-Gardner, William H. Hudson, et al. (+28)
20 [GO] 2021―Mar―14 Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite Gabriele Cerutti, Yicheng Guo, Tongqing Zhou, Jason Gorman, Myungjin Lee, Micah Rapp, et al. (+17)
21 [GO] 2021―Mar―11 The great escape? SARS-CoV-2 variants evading neutralizing responses Jérémie Prévost, Andrés Finzi
22 [GO] 2021―Mar―07 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, William Fischer, James Theiler, et al. (+11)
23 [GO] 2021―Feb―25 Robust SARS-CoV-2 Infection in Nasal Turbinates after Treatment with Systemic Neutralizing Antibodies Dongyan Zhou, Jasper Fuk-Woo Chan, Biao Zhou, Runhong Zhou, Shuang Li, Sisi Shan, et al. (+22)
24 [GO] 2021―Feb―24 One Year of SARS-CoV-2 Evolution Aiping Wu, Lulan Wang, Hang-Yu Zhou, Cheng-Yang Ji, Shang Zhou Xia, Yang Cao, et al. (+5)
25 [GO] 2021―Feb―09 Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies Allison J. Greaney, Andrea N. Loes, Katharine H.D. Crawford, Tyler N. Starr, Keara D. Malone, Helen Y. Chu, Jesse D. Bloom
26 [GO] 2021―Jan―29 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response Jing-wen Lin, Chao Tang, Han-cheng Wei, Baowen Du, Chuan Chen, Minjin Wang, et al. (+68)
27 [GO] 2021―Jan―27 Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, Paul W. Rothlauf, Rita E. Chen, Spencer Stumpf, et al. (+10)
28 [GO] 2021―Jan―14 Zooanthroponotic potential of SARS-CoV-2 and implications of re-introduction into human population Arinjay Banerjee, Karen Mossman, Michelle L. Baker
29 [GO] 2020―Dec―26 Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19 Qirui Guo, Yingchi Zhao, Junhong Li, Jiangning Liu, Xiuhong Yang, Xuefei Guo, et al. (+17)
30 [GO] 2020―Dec―17 Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors H.-Heinrich Hoffmann, Francisco J. Sánchez-Rivera, William M. Schneider, Joseph M. Luna, Yadira M. Soto-Feliciano, Alison W. Ashbrook, et al. (+13)
31 [GO] 2020―Dec―17 Intranasal Vaccination with a Lentiviral Vector Protects against SARS-CoV-2 in Preclinical Animal Models Min-Wen Ku, Maryline Bourgine, Pierre Authié, Jodie Lopez, Kirill Nemirov, Fanny Moncoq, et al. (+17)
32 [GO] 2020―Dec―09 FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein Vitor Hugo B. Serrão, Jeffrey E. Lee
33 [GO] 2020―Nov―20 Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, et al. (+14)
34 [GO] 2020―Nov―17 Integrative imaging reveals SARS-CoV-2 induced reshaping of subcellular morphologies Mirko Cortese, Ji-Young Lee, Berati Cerikan, Christopher J. Neufeldt, Viola M.J. Oorschot, Sebastian Köhrer, et al. (+23)
35 [GO] 2020―Nov―17 Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, Micah Rapp, Gabriele Cerutti, Gwo-Yu Chuang, et al. (+20)
36 [GO] 2020―Nov―13 Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles Maolin Lu, Pradeep D. Uchil, Wenwei Li, Desheng Zheng, Daniel S. Terry, Jason Gorman, et al. (+17)
37 [GO] 2020―Oct―07 Mining the Antibody Repertoire for Solutions to SARS-CoV-2 Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak
38 [GO] 2020―Oct―01 ACTIVating Resources for the COVID-19 Pandemic: In vivo Models for Vaccines and Therapeutics Judith A. Hewitt, Cathleen Lutz, William C. Florence, M. Louise M. Pitt, Srinivas Rao, Jay Rappaport, Nancy L. Haigwood
39 [GO] 2020―Oct―01 Accelerated preclinical paths to support rapid development of COVID-19 therapeutics Jay A. Grobler, Annaliesa S. Anderson, Prabhavathi Fernandes, Michael S. Diamond, Christine M. Colvis, Joseph P. Menetski, et al. (+3)
40 [GO] 2020―Sep―09 Snatching the Crown from SARS-CoV-2 Lynda Coughlan
41 [GO] 2020―Sep―09 Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M.E. Duyvesteyn, Helen M. Ginn, et al. (+19)
42 [GO] 2020―Sep―03 Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2 Sandra C.A. Nielsen, Fan Yang, Katherine J.L. Jackson, Ramona A. Hoh, Katharina Röltgen, Grace H. Jean, et al. (+19)
43 [GO] 2020―Aug―24 Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, et al. (+10)
44 [GO] 2020―Aug―10 Approaches and Challenges in SARS-CoV-2 Vaccine Development Gabriel Dagotto, Jingyou Yu, Dan H. Barouch
45 [GO] 2020―Jul―30 Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice James Brett Case, Paul W. Rothlauf, Rita E. Chen, Natasha M. Kafai, Julie M. Fox, Brittany Smith, et al. (+13)
46 [GO] 2020―Jul―18 Retrospective Multicenter Cohort Study Shows that Early Interferon Therapy is Associated with Favorable Clinical Responses in COVID-19 Patients Nan Wang, Yan Zhan, Linyu Zhu, Zhibing Hou, Feng Liu, Pinhong Song, et al. (+14)
47 [GO] 2020―Jul―03 Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. James Brett Case, Paul W. Rothlauf, Rita E. Chen, Zhuoming Liu, Haiyan Zhao, Arthur S. Kim, et al. (+19)
48 [GO] 2020―Jul―03 A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition M. Eugenia Dieterle, Denise Haslwanter, Robert H. Bortz, Ariel S. Wirchnianski, Gorka Lasso, Olivia Vergnolle, et al. (+17)
49 [GO] 2020―Jun―19 Neutralisation of SARS-CoV-2 by destruction of the prefusion Spike Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen ME. Duyvesteyn, Helen M. Ginn, et al. (+19)
50 [GO] 2020―May―27 Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19 Annsea Park, Akiko Iwasaki
51 [GO] 2020―May―27 A Mouse Model of SARS-CoV-2 Infection and Pathogenesis Shi-Hui Sun, Qi Chen, Hong-Jing Gu, Guan Yang, Yan-Xiao Wang, Xing-Yao Huang, et al. (+17)
52 [GO] 2020―May―20 The innate immune system: fighting on the front lines or fanning the flames of COVID-19? Julia L. McKechnie, Catherine A. Blish
53 [GO] 2020―May―14 FAVORABLE ANAKINRA RESPONSES IN SEVERE COVID-19 PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS George Dimopoulos, Quirijn de Mast, Nikolaos Markou, Maria Theodorakopoulou, Apostolos Komnos, Maria Mouktaroudi, et al. (+7)
54 [GO] 2020―May―14 Identification of Human Single-Domain Antibodies against SARS-CoV-2 Yanling Wu, Cheng Li, Shuai Xia, Xiaolong Tian, Yu Kong, Zhi Wang, et al. (+8)
55 [GO] 2020―May―13 Rational Vaccine Design in the Time of COVID-19 Dennis R. Burton, Laura M. Walker
56 [GO] 2020―May―13 SARS-CoV-2: A New Song Recalls an Old Melody Kanta Subbarao
57 [GO] 2020―May―13 The Challenges of Vaccine Development against a New Virus during a Pandemic Michael S. Diamond, Theodore C. Pierson
58 [GO] 2020―May―04 Heightened innate immune responses in the respiratory tract of COVID-19 patients Zhuo Zhou, Lili Ren, Li Zhang, Jiaxin Zhong, Yan Xiao, Zhilong Jia, et al. (+20)
59 [GO] 2020―Apr―30 A Dynamic Immune Response Shapes COVID-19 Progression Eugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, Natalie Mei Ying Lee, Shirin Kalimuddin, Salahudeen Mohamed Haja Mohideen, et al. (+5)
60 [GO] 2020―Apr―21 Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Evangelos J. Giamarellos-Bourboulis, Mihai G. Netea, Nikoletta Rovina, Karolina Akinosoglou, Anastasia Antoniadou, Nikolaos Antonakos, et al. (+22)
61 [GO] 2020―Apr―13 An Infectious cDNA Clone of SARS-CoV-2 Xuping Xie, Antonio Muruato, Kumari G. Lokugamage, Krishna Narayanan, Xianwen Zhang, Jing Zou, et al. (+10)
62 [GO] 2020―Apr―06 Infection and Rapid Transmission of SARS-CoV-2 in Ferrets Young-Il Kim, Seong-Gyu Kim, Se-Mi Kim, Eun-Ha Kim, Su-Jin Park, Kwang-Min Yu, et al. (+19)
63 [GO] 2020―Mar―16 A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 Alba Grifoni, John Sidney, Yun Zhang, Richard H. Scheuermann, Bjoern Peters, Alessandro Sette
64 [GO] 2020―Feb―07 Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China Aiping Wu, Yousong Peng, Baoying Huang, Xiao Ding, Xianyue Wang, Peihua Niu, et al. (+10)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.014 sec